Besides breast cancer, a putative relationship between MET and TGFBR2 expression was observed also in cell lines from other tumor entities using the NCI‐60 as well as the 789 cell line panels of the NCI and the Sanger Institute, respectively (Fig. S3B, C). This evidence concerns the gene MET and breast carcinoma.